| James B Kot, MD | |
|
54 Golf Club Rd, Hattiesburg, MS 39402-7953 | |
| (601) 261-0426 | |
| Not Available |
| Full Name | James B Kot |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery |
| Experience | 30 Years |
| Location | 54 Golf Club Rd, Hattiesburg, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144334814 | NPI | - | NPPES |
| 1559345 | Other | MS | AMERICAN ADMIN GROUP |
| 00124166 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 17256 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Forrest General Home Care | Hattiesburg, MS | Home health agency |
| Forrest General Hospital | Hattiesburg, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Forrest County General Hospital | 1052397767 | 85 |
News Archive
According to a new study by the National Institutes of Health, people with moderate to severe joint discomfort found that a combination of glucosamine and chondroitin resulted in significant pain and function improvement.
Data from 20 European national cancer registries was used to analyze trends in incidence rates of young adults with CRC across Europe over the last 25 years.
Three transplant patients have died as a result of receiving an organ from a donor who had unknowingly been infected with a common rodent virus. A fourth patient who received a kidney from the organ donor is recovering.
Keryx Biopharmaceuticals, Inc. today announced positive top-line results from the Phase 3 short-term efficacy study component of its Phase 3 registration program of Zerenex (ferric citrate), the Company's ferric iron-based phosphate binder for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.
› Verified 7 days ago
| Entity Name | Forrest County General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295837631 PECOS PAC ID: 1052397767 Enrollment ID: O20040624001351 |
News Archive
According to a new study by the National Institutes of Health, people with moderate to severe joint discomfort found that a combination of glucosamine and chondroitin resulted in significant pain and function improvement.
Data from 20 European national cancer registries was used to analyze trends in incidence rates of young adults with CRC across Europe over the last 25 years.
Three transplant patients have died as a result of receiving an organ from a donor who had unknowingly been infected with a common rodent virus. A fourth patient who received a kidney from the organ donor is recovering.
Keryx Biopharmaceuticals, Inc. today announced positive top-line results from the Phase 3 short-term efficacy study component of its Phase 3 registration program of Zerenex (ferric citrate), the Company's ferric iron-based phosphate binder for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James B Kot, MD 54 Golf Club Rd, Hattiesburg, MS 39402-7953 Ph: (601) 261-0426 | James B Kot, MD 54 Golf Club Rd, Hattiesburg, MS 39402-7953 Ph: (601) 261-0426 |
News Archive
According to a new study by the National Institutes of Health, people with moderate to severe joint discomfort found that a combination of glucosamine and chondroitin resulted in significant pain and function improvement.
Data from 20 European national cancer registries was used to analyze trends in incidence rates of young adults with CRC across Europe over the last 25 years.
Three transplant patients have died as a result of receiving an organ from a donor who had unknowingly been infected with a common rodent virus. A fourth patient who received a kidney from the organ donor is recovering.
Keryx Biopharmaceuticals, Inc. today announced positive top-line results from the Phase 3 short-term efficacy study component of its Phase 3 registration program of Zerenex (ferric citrate), the Company's ferric iron-based phosphate binder for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with end-stage renal disease on dialysis.
› Verified 7 days ago
Dr. Scott Eric Henry, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 5003 Hardy St Ste 200, Hattiesburg, MS 39402 Phone: 601-261-5700 Fax: 601-261-5777 | |
Lacy C Mcclain, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1011 S 34th Ave, Hattiesburg, MS 39402 Phone: 601-261-5163 | |
Robert J Robbins, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-268-5800 Fax: 601-261-3530 |